DAPARIDGETM Tablets contain Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor used in the management of type 2 diabetes mellitus. It works by reducing glucose reabsorption in the kidneys, thereby increasing glucose excretion through urine and lowering blood sugar levels. In addition to glycemic control, it offers added benefits such as weight management and cardiovascular support in appropriate patients.
Composition:
Key Features & Benefits:
- Effective Glycemic Control: Lowers blood glucose levels independently of insulin
- Weight Management Support: Promotes mild weight reduction through calorie loss
- Cardiometabolic Benefits: Associated with cardiovascular and renal protective effects
- Low Risk of Hypoglycemia: When used as monotherapy
- Once-Daily Regimen: Simplifies long-term diabetes management
Recommended Usage:
- To be taken as prescribed by a healthcare professional
- Can be taken with or without food
- Maintain adequate hydration during therapy
Safety Information:
- Not recommended in patients with severe renal impairment
- Use with caution in elderly patients and those at risk of dehydration
- May increase risk of urinary tract or genital infections
- Regular monitoring of blood glucose and renal function is advised
Storage Instructions:
- Store in a cool, dry place
- Protect from moisture and direct sunlight
- Keep out of reach of children
